Suppression of Acute and Chronic Cardiac Allograft Rejection in Mice by Inhibition of Chemokine Receptor 5 in Combination with Cyclosporine A

Journal of Surgical Research

Volumn 157, Issue 1, 2009, Pages 81-90

  Li, Jun ^a   Xia, Jiahong ^a   Zhang, Kailun ^a   Xu, Lei ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

acute ejection; anti CCR5 mAb; cardiac transplantation; CAV; CsA; immune system; pathology

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CCR5 ANTAGONIST; CYCLOSPORIN A;

ACUTE GRAFT REJECTION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL THERAPY; ARTICLE; CARDIAC GRAFT REJECTION; CHRONIC GRAFT REJECTION; CONTROLLED STUDY; DRUG MECHANISM; GRAFT SURVIVAL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION;

ACUTE DISEASE; ANIMALS; ANTIBODIES, MONOCLONAL; CHRONIC DISEASE; CYCLOSPORINE; DRUG THERAPY, COMBINATION; GRAFT REJECTION; GRAFT SURVIVAL; HEART TRANSPLANTATION; IMMUNOSUPPRESSIVE AGENTS; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RECEPTORS, CCR5; T-LYMPHOCYTES; TRANSPLANTATION, HOMOLOGOUS;

EID: 70349838689     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2009.01.014     Document Type: Article

References (42)

1. Weis M., and von Scheidt W. Cardiac allograft vasculopathy: A review. Circulation 96 (1997) 2069
2. Springer T.A. Traffic signals on endothelium for lymphocyte recirculation and leukocyte emigration. Annu Rev Physiol 57 (1995) 827
3. Flach R., Spieled N., Flohe S., et al. Analysis of intragraft cytokine expression during early reperfusion after liver transplantation using semi-quantitative RT-PCR. Cytokine 10 (1998) 445
4. Gu L., Tseng S., Horner R.M., et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature 404 (2000) 407
5. Murphy P.M., Baggiolini M., Charo I.F., et al. International Union of Pharmacology, XXII: Nomenclature for chemokine receptors. Pharmacol Rev 52 (2000) 145
6. Luster A.D. Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 338 (1998) 436
7. Yun J.J., Whiting D., Fischbein M.P., et al. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection. Circulation 109 (2004) 927
8. Yin R., Zhu J., Shao H., et al. Inhibition of Chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy. J Heart Lung Transplant 26 (2007) 485
9. Akashi S., Sho M., Kashizuka H., et al. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection. Transplantation 80 (2005) 378
10. Gao W., Faia K.L., Csizmadia V., et al. Beneficial effects of targeting CCR5 in allograft recipients. Transplantation 72 (2001) 1199
11. Corry R.J., Winn H.J., and Russell P.S. Primarily vascularized allografts of hearts in mice: The role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 16 (1973) 343
12. Fairchild R.L., VanBuskirk A.M., Kondo K., et al. Expression of chemokine genes during rejection and long-term acceptance of cardiac allografts. Transplantation 63 (1997) 1807
13. Armstrong A.T., Strach A., Starling R.C., et al. Morphometric analysis of neointimal formation in murine cardiac allografts. Transplantation 63 (1997) 941
14. Lurie K.G., Billingham M.E., Jamieson S.W., et al. Pathogenesis and prevention of graft atherosclerosis in an rat experimental heart transplantation model. Transplantation 31 (1981) 41
15. Hunter A.L., Kerjner A., Mueller K.J., McManus B.M., and Granville D.J. Cytochrome p450 2C enzymes contribute to peritransplant ischemic injury and cardiac allograft vasculopathy. Am J Transplant 8 (2008) 1631
16. Chavit C., Qiao J.H., Kobashigawa J., et al. Immunoperoxidase staining for C4d on paraffin-embedded tissue in cardiac allograft endomyocardial biopsies comparison to frozen tissue immunofluorescence. Appl Immunohistochem Mol Morphol 12 (2004) 166
17. Qian Z., Lee C.Y., Murata K., et al. Antibody and complement mediated injury in transplants following sensitization by allogeneic blood transfusion. Transplantation 82 (2006) 857
18. Benichou G., Valujskikh A., and Heeger P.S. Contributions of direct and indirect alloreactivity during allograft rejection in mice. J Immunol 162 (1999) 352
19. Zhang Q.W., Kish D.D., and Fairchild R.L. Absence of allograft ICAM-1 attenuates alloantigen-specific T cell priming, but not primed T cell trafficking into the graft, to mediate acute rejection. J Immunol 170 (2003) 5530
20. Xia D., Sanders A., Shah M., et al. Real-time polymerase chain reaction analysis reveals an evolution of cytokine mRNA production in allograft acceptor mice. Transplantation 72 (2001) 907
21. Fischbein M.P., Ardehali A., Yun J., et al. CD40 signaling replaces CD4+ lymphocytes and its blocking prevents chronic rejection of heart transplants. J Immunol 165 (2000) 7316
22. Waller J., Brook N.R., and Nicholson M.L. Cardiac allograft vasculopathy: Current concepts and treatment. Transplant Int 16 (2003) 367
23. VanBuskirk A.M., Pidwell D.J., Adams P.W., et al. Transplantation immunology. JAMA 278 (1997) 1993
24. Moien-Afshari F., McManus B.M., and Laher I. Immnosuppression and transplant vascular disease: Benefits and adverse effects. Pharmacol Yher 100 (2003) 141
25. Wood K.J., and Sakaguchi S. Regulatory T cells in transplantation tolerance. Nat Rev Immunol 3 (2003) 199
26. Hara M., Kingsley C.I., Niimi M., et al. IL-10 is required for regulatory T cells to mediate tolerance to alloantigens in vivo. J Immunol 166 (2001) 3789
27. Michaels P.J., Espejo M.L., Kobashigawa J., et al. Humoral rejection in cardiac transplantation: Risk factors, hemodynamic consequences and relationship to transplant coronary artery disease. J Heart Lung Transplant 22 (2003) 58
28. Lones M.A., Lawrence S.C., Alfredo T., et al. Clinical-pathologic features of humoral rejection in cardiac allografts: A study in 81 consecutive patients. J Heart Lung Transplant 14 (1995) 151
29. Taylor D.O., Yowell R.L., Kfoury A.G., et al. Allograft coronary artery disease: Clinical correlation with circulating anti-HLA antibodies and the immunohistopathologic pattern of vascular rejection. J Heart Lung Transplant 19 (2000) 518
30. Wu G.D., Jin Y.S., Salazar R., et al. Vascular endothelial cell apoptosis induced by anti-donor non-MHC antibodies: A possible injury pathway contribute to chronic allograft rejection. Transpl Immunol 21 (2002) 1174
31. Regele H., Exner M., Watschinger B., et al. Endothelial C4d deposition is associated with inferior kidney allograft outcome independently of cellular rejection. Nephrol Dial Transplant 16 (2001) 2058
32. Behr T.M., Feucht H.E., Richter K., et al. Detection of humoral rejection in human cardiac allografts by assessing the capillary deposition of complement fragment C4d in endomyocardial biopsies. J Heart Lung Transplant 18 (1999) 904
33. Bohming G.A., Exner M., Habitcht A., et al. Capillary C4d deposition in kidney allografts: A specific marker of alloantibody-dependent graft injury. J Am Nephrol 13 (2002) 1091
34. Bonnaud E.N., Lewis N.P., Masek M.A., et al. Reliability and usefulness of immunofluorescence in heart transplantation. J Heart Lung Transplant 14 (1995) 163
35. Haas M., Ratner L.E., and Montgonery R.A. C4d staining of perioperative renal transplantation biopsies. Transplantation 74 (2002) 711
36. Minami K., Murata K., Lee C.-Y., et al. C4d deposition and clearance in cardiac transplants correlates with alloantibody levels and rejection in rats. Am J Transplant 6 (2006) 923
37. Fishbein M.C., and Kobashigawa J. Biopsy-negative cardiac transplant rejection: Etiology, diagnosis, and therapy. Curr Opin Cardiol 19 (2004) 166
38. Ratliff N.B., and McMahon J.T. Activation of intravascular macrophages within myocardial small vessels is a feature of acute vascular rejection in human heart transplantation. J Heart Lung Transplant 14 (1995) 338
39. Schroder C., Pierson III R.N., Nguyen B.N., et al. CCR5 blockade modulates inflammation and alloimmunity in primates. J Immunol 179 (2007) 2289
40. Loestcher M., Gerber P.L., Jones S.A., et al. Chemokine receptor specific for IP10 and mig: Structure, function, and expression in activated T-lymphocytes. J Exp Med 184 (1996) 963
41. Sozzni S., Allavena P., Amico G.D., et al. Cutting edge: Differential regulation of chemokine receptors during dendritic cell maturation: A model for their trafficking properties. J Immunol 161 (1998) 1083
42. Wysocki C.A., Jiang Q., Panoskaltsis M., et al. Critical role for CCR5 in the function of donor CD4+CD25+ regulatory T cells during acute graft-versus-host disease. Blood 106 (2005) 3300